FSD Pharma scales down Cannabis cultivation
As announced in April, FSD Pharma is selling their Cobourg building and Bloomberg reports that that part of the business (cannabis cultivation) has been scaled down to a bare minimum. Instead, the company will “double down on our biosciences and specialty R&D pharmaceutical efforts”. In line with this, on June 3 they announced that they had received U.S. Food and Drug Administration approval to design a proof-of-concept study for a potential Covid-19 treatment. But this drug does not involve any sort of cannabis-derived compound which implies that growing marijuana plants is no longer where they see their future. It looks like Cobourg’s hope that they would provide large employment opportunities has gone. Perhaps a new owner of the building will… Read complete articleFSD Pharma scales down Cannabis cultivation